[1]
R. Jurema Medeiros, N. Pessoa Gonçalves, M. Maciel Magalhães, J. Ferreira Martins, e T. Savignon Cardoso Machado, “Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e01923 | Publicado em: 11/05/2023”, Vigil Sanit Debate, vol. 11, p. 1–10, maio 2023.